zearalenol and 3-nitrotyrosine

Hyperhomocysteinemia is strongly associated with cardiovascular diseases. Previous studies have shown that phytoestrogen α-zearalanol can protect cardiovascular system from hyperhomocysteinemia and ameliorate the level of plasma total homocysteine; however, the underlying mechanisms remain to be clarified. The aim of this research is to investigate the possible molecular mechanisms involved in ameliorating the level of plasma homocysteine by α-zearalanol. By the successfully established diet-induced hyperhomocysteinemia rat models, we found that, after α-zearalanol treatment, the activity of cystathionine β-synthase, the key enzyme in homocysteine metabolism, was significantly elevated and level of nitrative stress in liver was significantly reduced. In correlation with this, results also showed a decreased nitration level of cystathionine β-synthase in liver. Together data implied that alleviation of plasma homocysteine level by phytoestrogen α-zearalanol might be related to the reduction of cystathionine β-synthase nitration.

Topics: Animals; Cystathionine beta-Synthase; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Female; Homocysteine; Hyperhomocysteinemia; Liver; Nitrates; Oxidation-Reduction; Phytoestrogens; Rats; Rats, Wistar; Treatment Outcome; Tyrosine; Zeranol